Merck & Co., Inc. (NYSE:MRK) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, ...

Sarepta Therapeutics ( NASDAQ: SRPT) was upgraded to Neutral from Underweight at J.P. Morgan as it sees FDA's Elevidys hold removal recommendation in ambulatory patients as a clear win.

Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...

Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major ...

Detailed price information for Integer Holdings Corp (ITGR-N) from The Globe and Mail including charting and trades.

Oppenheimer analyst Brian Nagel sees upside in Carvana stock to $450. CVNA is set to report its fiscal second-quarter ...

Analysts upgraded Carvana shares, arguing the company is a "digitally-driven disruptor" in the fractured used car market.

Carvana ( NYSE: CVNA) tracked higher on Friday after Oppenheimer boosted its rating on the auto retailer to Outperform after ...

In a recent market update, Boston Scientific’s financial trajectory got a new spin with Oppenheimer raising its price target ...

Oppenheimer upgraded Spotify (NYSE:SPOT) to Outperform with a $800 price target on strong upside from user growth, advertising monetization.Shares are up 1.7% at $685.78 on Thus. trading. Spotify ...

Fintel reports that on July 21, 2025, Oppenheimer initiated coverage of Affirm Holdings (NasdaqGS:AFRM) with a Outperform ...

Affirm presents investors an opportunity to “buy now, gain later,” say Oppenheimer analysts who set an $80 price target.